Published in Eur J Immunol on May 01, 1994
Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc Natl Acad Sci U S A (1996) 1.71
CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J Exp Med (1996) 1.35
CD38 and chronic lymphocytic leukemia: a decade later. Blood (2011) 1.33
Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med (1995) 1.01
Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature. Antioxid Redox Signal (2014) 0.94
Follicular dendritic cells inhibit apoptosis in human B lymphocytes by a rapid and irreversible blockade of preexisting endonuclease. J Exp Med (1995) 0.93
Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia. J Clin Invest (1998) 0.86
Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice. Eur J Immunol (2001) 0.85
The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia. Ann Hematol (2013) 0.83
CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation. Proc Natl Acad Sci U S A (2000) 0.82
Anti-CD38 autoantibodies in type? diabetes. Diabetes Metab Res Rev (2006) 0.78
Characterization and phylogenetic epitope mapping of CD38 ADPR cyclase in the cynomolgus macaque. BMC Immunol (2004) 0.76
TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells. J Immunol (2015) 0.76
Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight (2016) 0.75
Immunotherapies targeting CD38 in Multiple Myeloma. Oncoimmunology (2016) 0.75
CD38 ligation in peripheral blood mononuclear cells of myeloma patients induces release of protumorigenic IL-6 and impaired secretion of IFNγ cytokines and proliferation. Mediators Inflamm (2013) 0.75
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood (1999) 11.57
Expression of a receptor for IgM by human T cells in vitro. Eur J Immunol (1975) 5.05
Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J Immunol (1976) 4.64
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96
Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells. Eur J Immunol (1975) 3.26
Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J Immunol (2000) 3.13
The release of platelet-activating factor from human endothelial cells in culture. J Immunol (1983) 2.41
Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast. J Pathol (2001) 1.78
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71
Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat Med (2001) 1.66
Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol (2000) 1.64
Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol (1998) 1.59
Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species. J Med Microbiol (1988) 1.54
Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis. J Immunol (1985) 1.52
A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes. Biochem Biophys Res Commun (1993) 1.52
The demonstration of acid alpha-naphthyl acetate esterase activity in human lymphocytes: usefulness as a T-cell marker. Cell Immunol (1978) 1.52
Two novel Italian CADASIL families from Central Italy with mutation CGC-TGC at codon 1006 in the exon 19 Notch3 gene. Neurol Sci (2006) 1.51
The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation. Blood (1989) 1.51
Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As(2)O(3)) on myeloma cells. Leuk Res (2001) 1.46
Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J Immunol (1994) 1.44
Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study. Clin Exp Rheumatol (1993) 1.43
Characterization of human T-cell subpopulations as defined by specific receptors for immunoglobulins. Contemp Top Immunobiol (1978) 1.42
Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res (2001) 1.41
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis (2012) 1.40
Ultrastructure and cytochemistry of human peripheral blood lymphocytes. Similarities between the cells of the third population and TG lymphocytes. Eur J Immunol (1980) 1.38
Receptors for IgM on certain human B lymphocytes. J Immunol (1977) 1.37
CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood (1996) 1.35
Human T cell receptor for IgM: specificity for the pentameric Fc fragment. Eur J Immunol (1976) 1.30
Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS (2000) 1.30
Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest (1985) 1.30
Human CD38, a cell-surface protein with multiple functions. FASEB J (1996) 1.29
Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol (1990) 1.28
Human lymphocytes bearing "Ia-like" antigens; absence in patients with infantile agammaglobulinemia. J Immunol (1977) 1.26
In vitro selective expansion of allergen specific T cells from atopic patients. Clin Exp Immunol (1983) 1.21
Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions. J Med Microbiol (1986) 1.20
Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS (2001) 1.19
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med (1995) 1.17
Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology (2007) 1.16
Large granular lymphocytes in human peripheral blood: ultrastructural and cytochemical characterization of the granules. Blood (1982) 1.16
Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood (2000) 1.16
Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat Biotechnol (2000) 1.10
Comparison of various tests for Fc receptors on different human lymphocyte sub populations. Clin Exp Immunol (1979) 1.10
Isoform-specific associations of CD45 with accessory molecules in human T lymphocytes. Eur J Immunol (1992) 1.09
Selective lysis of the autologous tumor by delta TCS1+ gamma/delta+ tumor-infiltrating lymphocytes from human lung carcinomas. Eur J Immunol (1990) 1.09
Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology (2004) 1.08
In vitro production of interleukin 1 by normal and malignant human B lymphocytes. J Immunol (1986) 1.08
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. Leukemia (2012) 1.07
CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. Leukemia (2010) 1.06
CD38 functions are regulated through an internalization step. J Immunol (1998) 1.06
Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response. J Exp Med (1987) 1.05
Secretion of IFN-gamma, IL-6, granulocyte-macrophage colony-stimulating factor and IL-10 cytokines after activation of human purified T lymphocytes upon CD38 ligation. Cell Immunol (1996) 1.05
CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells. J Immunol (1990) 1.04
CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes. Chem Immunol (2000) 1.04
A study of immunoglobulin classes present on the membrane and in the cytoplasm of human tonsil plasma cells. Eur J Immunol (1976) 1.04
Human T cell lines with antigen specificity and helper activity. Eur J Immunol (1982) 1.04
Fc-receptors for IgG and IgM immunoglobulins on human T lymphocytes: mode of re-expression after proteolysis or interaction with immune complexes. J Immunol (1978) 1.04
Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitro. Hum Immunol (1985) 1.03
Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells. Hum Immunol (1984) 1.03
CD38 triggers cytotoxic responses in activated human natural killer cells. Blood (1999) 1.02
HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: a model for a persistent "self-limiting" HIV-1 infection. Virology (1994) 1.02
Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas. Leukemia (1999) 1.01
An in vitro model for Toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites. J Immunol (1988) 1.01
Comparative study of membrane and intracytoplasmic immunoglobulin classes in human lymphoid cells. Ann N Y Acad Sci (1975) 1.01
Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med (1995) 1.01
Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Cancer Res (1994) 1.01
Lymphocyte membrane receptors in human lymphoid leukemias. Eur J Immunol (1975) 1.00
Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur J Immunol (1993) 1.00
Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells. J Immunol (1996) 1.00
Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. J Biol Regul Homeost Agents (1998) 1.00
Characterization of IgD. I. Isolation of two molecular forms from human serum. Scand J Immunol (1979) 1.00
The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma. Blood Cancer J (2012) 1.00
T-cell receptor V delta gene usage by tumour reactive gamma delta T lymphocytes infiltrating human lung cancer. Immunology (1994) 1.00
Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood (1997) 0.99
Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes. Proc Natl Acad Sci U S A (1986) 0.99
Increased serum IgD concentrations in patients with Hodgkin's disease. Clin Exp Immunol (1977) 0.99
Signaling through CD38 induces NK cell activation. Int Immunol (2001) 0.98
Large granular lymphocytes have a promoting activity on human peripheral blood erythroid burst-forming units. Blood (1985) 0.98
Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. Blood (1996) 0.97
Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL). J Immunol (1985) 0.97
Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid. Biochem Biophys Res Commun (1993) 0.97
Identification and characterization of an active soluble form of human CD38 in normal and pathological fluids. Int Immunol (1996) 0.96
Sensitivity study of CR39 track detector in an extended range Bonner sphere spectrometer. Radiat Prot Dosimetry (2007) 0.96
Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia. Blood (1985) 0.96
rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues. J Immunol (1999) 0.95
Presence of serum IgD and IgD-containing plasma cells in the mouse. Eur J Immunol (1979) 0.95
Autocrine nitric oxide modulates CD95-induced apoptosis in gammadelta T lymphocytes. J Biol Chem (1997) 0.95
A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J Immunol (1994) 0.94
Lymphocyte adhesion to endothelium. Crit Rev Immunol (1995) 0.94
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells. J Clin Invest (1996) 0.94
The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene. Immunogenetics (1999) 0.94